Kumar A, Benson L, Wymore E, Phipers J, Dempsey J, Cort L
Nat Commun. 2025; 16(1):824.
PMID: 39827121
PMC: 11743202.
DOI: 10.1038/s41467-025-55863-5.
Benzi J, Tsang Y, Unadkat J
Front Pharmacol. 2024; 15:1440010.
PMID: 39170705
PMC: 11335556.
DOI: 10.3389/fphar.2024.1440010.
Allegaert K, Quinney S, Dallmann A
Pharmaceutics. 2024; 16(4).
PMID: 38675161
PMC: 11053422.
DOI: 10.3390/pharmaceutics16040500.
Authement A, Isoherranen N
Expert Opin Drug Metab Toxicol. 2024; 20(1-2):73-93.
PMID: 38258511
PMC: 11044908.
DOI: 10.1080/17425255.2024.2309213.
Le Merdy M, Szeto K, Perrier J, Bolger M, Lukacova V
Pharmaceutics. 2024; 16(1).
PMID: 38258106
PMC: 10820132.
DOI: 10.3390/pharmaceutics16010096.
A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy.
Gong C, Bertagnolli L, Boulton D, Coppola P
Pharmaceutics. 2023; 15(11).
PMID: 38004602
PMC: 10674389.
DOI: 10.3390/pharmaceutics15112624.
Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations.
Chothe P, Arya V, Prasad B, Ramsden D, Taskar K
Drug Metab Dispos. 2023; 51(12):1547-1550.
PMID: 37775331
PMC: 10658904.
DOI: 10.1124/dmd.123.001453.
Pregnancy related hormones increase CYP3A mediated buprenorphine metabolism in human hepatocytes: a comparison to CYP3A substrates nifedipine and midazolam.
Fashe M, Miner T, Fallon J, Schauer A, Sykes C, Smith P
Front Pharmacol. 2023; 14():1218703.
PMID: 37475714
PMC: 10354249.
DOI: 10.3389/fphar.2023.1218703.
Design Considerations for Pharmacokinetic Studies During Pregnancy.
Stika C, Hebert M
J Clin Pharmacol. 2023; 63 Suppl 1:S126-S136.
PMID: 37317491
PMC: 10350295.
DOI: 10.1002/jcph.2238.
Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women.
Song Y, Wang W, Liu X, Chen J, Chen D, Wang X
Pharm Res. 2023; 40(7):1765-1775.
PMID: 37142805
DOI: 10.1007/s11095-023-03523-y.
A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy.
Alshabi A, Shaik I, Zhao Y, Pillai V, Caritis S, Venkataramanan R
Eur J Clin Pharmacol. 2023; 79(6):815-827.
PMID: 37060457
PMC: 10105140.
DOI: 10.1007/s00228-023-03489-1.
Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure.
Hudson R, Metz T, Ward R, McKnite A, Enioutina E, Sherwin C
Front Pharmacol. 2023; 14:1111601.
PMID: 37033628
PMC: 10076747.
DOI: 10.3389/fphar.2023.1111601.
Renal function estimating equations performance during pregnancy and postpartum.
Zaghloul D, Ryu R, Kestenbaum B, Smith C, Fay E, Hebert M
Pharmacotherapy. 2023; 43(5):359-371.
PMID: 37021950
PMC: 10192202.
DOI: 10.1002/phar.2800.
The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK Modeling.
Alsmadi M, Idkaidek N
Eur J Drug Metab Pharmacokinet. 2023; 48(3):281-300.
PMID: 37017867
DOI: 10.1007/s13318-023-00823-x.
Plasma hydrogen sulfide, nitric oxide, and thiocyanate levels are lower during pregnancy compared to postpartum in a cohort of women from the Pacific northwest of the United States.
Zeigler M, Fay E, Moreni S, Mao J, Totah R, Hebert M
Life Sci. 2023; 322:121625.
PMID: 37001802
PMC: 10133030.
DOI: 10.1016/j.lfs.2023.121625.
PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia.
Macente J, Nauwelaerts N, Russo F, Deprest J, Allegaert K, Lammens B
Front Pharmacol. 2023; 14:1068153.
PMID: 36998614
PMC: 10043195.
DOI: 10.3389/fphar.2023.1068153.
Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.
Starodubtseva N, Kindysheva S, Potapova A, Kukaev E, Khodzhaeva Z, Bockeria E
Int J Mol Sci. 2023; 24(3).
PMID: 36768172
PMC: 9916042.
DOI: 10.3390/ijms24031848.
Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio.
Mlugu E, Minzi O, Kamuhabwa A, Diczfalusy U, Aklillu E
Int J Mol Sci. 2022; 23(23).
PMID: 36499500
PMC: 9739497.
DOI: 10.3390/ijms232315168.
Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis.
Merino D, Gerard A, Destere A, Askenazy F, Drici M, Thummler S
Biomedicines. 2022; 10(11).
PMID: 36428541
PMC: 9687123.
DOI: 10.3390/biomedicines10112972.
Impact of Pregnancy and Vitamin A Supplementation on CYP2D6 Activity.
Amaeze O, Czuba L, Yadav A, Fay E, LaFrance J, Shum S
J Clin Pharmacol. 2022; 63(3):363-372.
PMID: 36309846
PMC: 9931631.
DOI: 10.1002/jcph.2169.